(AP Photo/Heather Khalifa) Jake Heinrichs prepares for his infusion treatment with an experimental anti-amyloid Alzheimer’s drug while at home in New York, on Wednesday, March 12, 2025. (AP ...

An illustration depicts cells in an Alzheimer’s-affected brain, with abnormal levels of beta amyloid protein clumping together to form plaques that collect between neurons and disrupt cell function.

Gantenerumab helps eliminate one of the neurological hallmarks of Alzheimer’s, called amyloid plaques. For some participants, gantenerumab reduced their risk of developing the disease by more ...

One year earlier, in June 2021, the US Food and Drug Administration had approved aducanumab, an antibody-targeting beta-amyloid, as a treatment for Alzheimer's, even though the data supporting its use ...

The agency cleared the drug, called Amvuttra, for people with a cardiac form of the rare disease transthyretin amyloidosis. Alnylam already ... is very high in the neuropathy form of ATTR. “You don’t ...

Both early-onset and late-onset Alzheimer's disease start with amyloid slowly collecting in the brain two decades before memory and thinking problems arise. Further, all trial results from these ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains of people destined to develop Alzheimer’s dementia can ...

The findings suggest -- for the first time in a clinical trial -- that early treatment to remove amyloid plaques from the brain many years before symptoms arise can delay the onset of Alzheimer's ...

McDade said this study has the longest-running data for any patients who started amyloid-lowering biologics while they were still free of symptoms. “We think that there’s a delay in the ...

and Joanne Knight Distinguished Professor of Neurology at WashU Medicine, is the study director of an international clinical trial that finds an anti-amyloid drug can delay the onset of cognitive ...

Alzheimer's is currently incurable once symptoms begin, but scientists are hoping it's possible to stop its progression with early enough treatment. © sfam_photo via ...

The study team set out to test how effective combining 11 C-PiB PET/CT and 99m Tc-DPD scintigraphy would be in detecting cardiac amyloidosis and differentiating between light chain and transthyretin ...